Cheng Wu
- Molecular Biology
- Neurology top 10%
- Cancer Research
- Neurology top 10%
- Physiology
- Topics
- Pain Mechanisms and Treatments (8 papers)Cancer, Hypoxia, and Metabolism (5 papers)Pain Management and Placebo Effect (4 papers)
- Cited by
- Biological PsychiatryNeurology
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Cheng Wu
34 papers receiving 877 citations
Peers
Comparison fields: 5 of 96
- Molecular Biology 408
- Neurology 189
- Cancer Research 133
- Neurology 125
- Physiology 118
Countries citing papers authored by Cheng Wu
This map shows the geographic impact of Cheng Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheng Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheng Wu more than expected).
Fields of papers citing papers by Cheng Wu
This network shows the impact of papers produced by Cheng Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheng Wu. The network helps show where Cheng Wu may publish in the future.
Co-authorship network of co-authors of Cheng Wu
This figure shows the co-authorship network connecting the top 25 collaborators of Cheng Wu. A scholar is included among the top collaborators of Cheng Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cheng Wu. Cheng Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | 15 | |
| 4 | 1 | |
| 5 | 1 | |
| 6 | 28 | |
| 7 | 39 | |
| 8 | 8 | |
| 9 | 24 | |
| 10 | 3 | |
| 11 | 85 | |
| 12 | 16 | |
| 13 | 35 | |
| 14 | 42 | |
| 15 | 16 | |
| 16 | 145 | |
| 17 | 38 | |
| 18 | 28 | |
| 19 | 150 | |
| 20 | In vitro growth inhibition by indomethacin on human oral squamous cell carcinoma lines synergistically suppressed by all-trans retinoic acid correlating to apoptosis. | 1 |
About Cheng Wu
Cheng Wu is a scholar working on Cancer Research, Neurology and Physiology, having authored 34 papers that have together received 886 indexed citations. Recurring topics across this work include Pain Mechanisms and Treatments (8 papers), Cancer, Hypoxia, and Metabolism (5 papers) and Pain Management and Placebo Effect (4 papers). The work is most often cited by research in Biological Psychiatry (41 citations), Neurology (125 citations) and Neurology (189 citations). Cheng Wu has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Feng Yan, Gao Chen, Jianru Li, Chi Gu, Lin Wang, Jingyin Chen, Brandon Dixon, Qiang Hu, Shuxu Yang and Yirong Wang. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nature Communications and Brain Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.